.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Fuji
Cerilliant
Accenture
Queensland Health
Dow
Daiichi Sankyo
Cipla
Healthtrust
Julphar

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206581

« Back to Dashboard
NDA 206581 describes IBUPROFEN SODIUM, which is a drug marketed by Perrigo R And D and is included in one NDA. It is available from six suppliers. Additional details are available on the IBUPROFEN SODIUM profile page.

The generic ingredient in IBUPROFEN SODIUM is ibuprofen sodium. There are sixty-three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ibuprofen sodium profile page.

Summary for NDA: 206581

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 206581

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IBUPROFEN SODIUM
ibuprofen sodium
TABLET;ORAL 206581 ANDA Walgreen Company 0363-0909 0363-0909-27 1 BOTTLE in 1 CARTON (0363-0909-27) > 80 TABLET, FILM COATED in 1 BOTTLE
IBUPROFEN SODIUM
ibuprofen sodium
TABLET;ORAL 206581 ANDA Walgreen Company 0363-0909 0363-0909-49 1 BOTTLE in 1 CARTON (0363-0909-49) > 40 TABLET, FILM COATED in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Aug 3, 2015TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
McKesson
Fuji
Farmers Insurance
Medtronic
QuintilesIMS
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot